[go: up one dir, main page]

WO2006028497A3 - Active recombinant human lysozyme - Google Patents

Active recombinant human lysozyme Download PDF

Info

Publication number
WO2006028497A3
WO2006028497A3 PCT/US2005/005291 US2005005291W WO2006028497A3 WO 2006028497 A3 WO2006028497 A3 WO 2006028497A3 US 2005005291 W US2005005291 W US 2005005291W WO 2006028497 A3 WO2006028497 A3 WO 2006028497A3
Authority
WO
WIPO (PCT)
Prior art keywords
recombinant human
human lysozyme
active recombinant
agent
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/005291
Other languages
French (fr)
Other versions
WO2006028497A2 (en
Inventor
Arabinda Mandal
John C Herr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UVA Licensing and Ventures Group
University of Virginia UVA
Original Assignee
University of Virginia UVA
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA, University of Virginia Patent Foundation filed Critical University of Virginia UVA
Publication of WO2006028497A2 publication Critical patent/WO2006028497A2/en
Publication of WO2006028497A3 publication Critical patent/WO2006028497A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to a method of preparing and isolating active recombinant human lysozyme and other proteins by rapid folding. The present invention also relates a method of using such a protein as a bacteriostatic agent, a bacteriocidal agent, an antifungal agent, and an antiviral agent.
PCT/US2005/005291 2004-02-20 2005-02-22 Active recombinant human lysozyme Ceased WO2006028497A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54614104P 2004-02-20 2004-02-20
US60/546,141 2004-02-20

Publications (2)

Publication Number Publication Date
WO2006028497A2 WO2006028497A2 (en) 2006-03-16
WO2006028497A3 true WO2006028497A3 (en) 2006-07-27

Family

ID=36036764

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/005291 Ceased WO2006028497A2 (en) 2004-02-20 2005-02-22 Active recombinant human lysozyme

Country Status (1)

Country Link
WO (1) WO2006028497A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12447166B2 (en) 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
CN117942405A (en) 2016-02-25 2024-04-30 应用生物实验室公司 Compositions and methods for protecting airborne pathogens and irritants
CN109628430A (en) * 2018-12-04 2019-04-16 浙江理工大学 Virus type from cristaria plicata gene recombinates lysozyme
DK3997118T3 (en) 2019-07-11 2025-03-24 Clara Foods Co BEVERAGE COMPOSITION CONTAINING RECOMBINANT OVOMUCOID PROTEIN
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
BR112022012630A2 (en) * 2019-12-24 2022-09-06 Clara Foods Co ENZYME COMPOSITIONS AND METHODS FOR PRODUCING THEM.
CN119639721B (en) * 2025-02-20 2025-05-09 腾讯科技（深圳）有限公司 Polypeptides and uses thereof, methods for preparing polypeptides, compositions or kits

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618712A (en) * 1985-11-12 1997-04-08 Boehringer Ingelheim Zentrale Gmbh Human lysozyme
US20050095612A1 (en) * 1997-08-19 2005-05-05 Human Genome Sciences, Inc. 70 human secreted proteins
US20050118594A1 (en) * 2001-12-14 2005-06-02 Chawla Narinder K. Enzymes
US20050191627A1 (en) * 2001-09-28 2005-09-01 Incyte Corporation Enzymes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618712A (en) * 1985-11-12 1997-04-08 Boehringer Ingelheim Zentrale Gmbh Human lysozyme
US20050095612A1 (en) * 1997-08-19 2005-05-05 Human Genome Sciences, Inc. 70 human secreted proteins
US20050191627A1 (en) * 2001-09-28 2005-09-01 Incyte Corporation Enzymes
US20050118594A1 (en) * 2001-12-14 2005-06-02 Chawla Narinder K. Enzymes

Also Published As

Publication number Publication date
WO2006028497A2 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
WO2003025018A3 (en) Dimeric and multimeric antigen binding structure
WO2005001025A3 (en) Immunoglobulin chimeric monomer-dimer hybrids
WO2003011115A3 (en) Peptide-based multimeric targeted contrast agents
WO2006119107A3 (en) Sclerostin binding agents
WO2006117217A3 (en) Novel use of spiegelmers
WO2005118620A3 (en) Methods for preparing internally constraied peptides and peptidomimetics
WO2007002261A3 (en) IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
WO2007064917A3 (en) Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
WO2008079995A3 (en) Conjugate of natriuretic peptide and antibody constant region
WO2002099084A3 (en) Composite binding polypeptides
EP2628749A3 (en) Antimicrobial kinocidin compostions and methods of use
WO2005067601A3 (en) Vectors for recombinant protein expression in e.coli
WO2006127757A3 (en) Interferon-igg fusion
WO2007035716A3 (en) Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
WO2005009378A3 (en) Polypeptides for inducing a protective immune response against staphylococcus aureus
EP1969127B8 (en) Method of producing biologically active vitamin k dependent proteins by recombinant methods
WO2004098536A3 (en) Anti-viral activity of cathelicidin peptides
WO2006028497A3 (en) Active recombinant human lysozyme
AU2003201727A1 (en) Recombinant protein expression
MXPA03011158A (en) Solution structure of il-13 and uses thereof.
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
WO2008024919A8 (en) Interferon antagonists, antibodies thereto, and associated methods of use
WO2005081873A9 (en) Il-13 mutein proteins, antibodies, compositions, methods and uses
WO2007019865A3 (en) Therapy with cd4 binding peptides and radiation
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase